Profiling CD8+ T cell epitopes of COVID-19 convalescents reveals reduced cellular immune responses to SARS-CoV-2 variantsHang Zhang, Xu Tan, Shasha Deng et al.|Cell Reports|2021Cited by 70
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including OmicronHuan Ma, Tengchuan Jin, Peter H. Dube et al.|Cell Research|2022Cited by 41
A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administrationHuan Ma, Sandra Chiu, Xinghai Zhang et al.|Cell Discovery|2022Cited by 37
Hetero-bivalent Nanobodies Provide Broad-spectrum Protection against SARS-CoV-2 Variants of Concern including OmicronHuan Ma, Tengchuan Jin, Xinghai Zhang et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 1